Solution reagent kit TruSight®

NGSfor DNA analysisfor RNA analysis

These enrichment-based next-generation sequencing (NGS) reagents enable simultaneous analysis of DNA and RNA, and can cover a wide range of cancer variant types. This methodology provides laboratories with a deep view into the genetics of cancer. Accurate Results from Low-Quality Samples1 Enables variant detection with as little as 40 ng DNA and RNA input, maximizing the results from precious formalin-fixed, paraffin-embedded (FFPE) samples. Supports Comprehensive Coverage of Cancer-Related Variants Allows the assessment of multiple variant types in one assay using DNA and RNA which creates efficiencies in sample usage, time, and cost. Integrated, Streamlined Workflow DNA and RNA are prepared in parallel with an integrated workflow following DNA shearing/cDNA synthesis. Flexible Applications Enrichment-based workflow allows for a wide variety of content, input types, and applications.